About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Lung Cancer
›
top-articles
Lung Cancer
2.4
(top 20%)
impact factor
16.6K
(top 1%)
papers
241.4K
(top 2%)
citations
152
(top 2%)
h
-index
2.5
(top 20%)
impact factor
24.3K
all documents
254.0K
doc citations
211
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
Lung Cancer
1996
741
2
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
Lung Cancer
1995
652
3
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Lung Cancer
2017
631
4
Metastatic sites and survival in lung cancer
Lung Cancer
2014
590
5
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
Lung Cancer
2012
556
6
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
Lung Cancer
2004
553
7
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
Lung Cancer
2015
454
8
Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer
Lung Cancer
2005
445
9
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
Lung Cancer
1998
434
10
Complete resection in lung cancer surgery: proposed definition
Lung Cancer
2005
417
11
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
Lung Cancer
2001
407
12
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Lung Cancer
2017
403
13
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
Lung Cancer
2004
400
14
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
Lung Cancer
2002
392
15
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Lung Cancer
2011
381
16
Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers
Lung Cancer
2015
369
17
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
Lung Cancer
1999
367
18
Radiomics and radiogenomics in lung cancer: A review for the clinician
Lung Cancer
2018
362
19
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
Lung Cancer
2009
357
20
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?
Lung Cancer
2002
327
21
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
Lung Cancer
2006
322
22
A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer
Lung Cancer
2002
320
23
The relationship between COPD and lung cancer
Lung Cancer
2015
320
24
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
Lung Cancer
1999
314
25
Nodule management protocol of the NELSON randomised lung cancer screening trial
Lung Cancer
2006
313
26
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
Lung Cancer
2018
313
27
Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
Lung Cancer
2006
310
28
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
Lung Cancer
2012
308
29
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images
Lung Cancer
2004
304
30
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial
Lung Cancer
2006
304
31
International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women
Lung Cancer
2014
303
32
Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distress
Lung Cancer
2007
301
33
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
Lung Cancer
2010
301
34
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Lung Cancer
2004
297
35
MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
Lung Cancer
2009
297
36
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)
Lung Cancer
2000
293
37
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Lung Cancer
2006
290
38
Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung
Lung Cancer
2003
289
39
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies
Lung Cancer
2010
289
40
The role of radiotherapy in treatment of stage I non-small cell lung cancer
Lung Cancer
2003
283
41
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report
Lung Cancer
2004
282
42
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer
Lung Cancer
2005
278
43
Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study
Lung Cancer
2005
276
44
An investigation on electronic nose diagnosis of lung cancer
Lung Cancer
2010
271
45
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
Lung Cancer
2010
268
46
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
Lung Cancer
2013
268
47
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study
Lung Cancer
1998
266
48
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
Lung Cancer
2009
265
49
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
Lung Cancer
2005
263
50
PIK3CA mutation status in Japanese lung cancer patients
Lung Cancer
2006
262
site/software ©
exaly
; All materials licenced under
CC by-SA
.